News
Stay informed about the latest developments and achievements from TRICALS.
Subscribe to our newsletterAll news
news
April 4, 2022
Measuring treatment effects based on patient preference
Read more
news
March 15, 2022
TRICALS Enrols First Participants in Phase 3 MAGNET platform trial for ALS
Read more
news
January 13, 2022
USA: new law promises $100 million for ALS research
Read more
news
December 7, 2021
Congratulations to our TRICALS colleagues as UK Government invests £50 million to find a cure for ALS
Read more
news
November 16, 2021
ADORE trial enrolls first patient
Read more
news
November 8, 2021
First participants enrolled in PHOENIX trial
Read more
news
October 26, 2021
A road map for digital health care technology in MND
Read more
news
August 12, 2021
More patients eligible for clinical trials through innovative study design
Read more
news
April 14, 2021
Amylyx Pharmaceuticals and TRICALS to collaborate on phase 3 clinical trial
Read more
news
March 22, 2021
Retrotope announces initiation of RT001 study in people with ALS
Read more
news
March 12, 2021
Virtual ENCALS meeting 2021
Read more
news
December 24, 2020
Reconsidering the ALSFRS-R for ALS clinical trials
Read more
news
December 22, 2020
Summary of the 31st International Symposium on ALS/MND
Read more